Quote:
Originally Posted by shayna
The problem is that I really want to be on Tysabri but I also want more info. With the TOUCH program Biogen must have all the info it needs about the 11 PML cases. I would like to know what the commonalities are other than the length of time the patients were on Tysabri before developing PML.
|
Shayna,
Biogen does have very detailed info on the 11 PML cases (importantly includes detailed info from 2 patients prior to their PML diagnoses because they were in the STRATA trial). They have communicated in their earnings conferences calls that they are aggressively pursuing several possible risk factors. I stress the word possible as they are scientists and they want proof/confirmation and validation with outside experts on the JC virus rather than coming to a quick conclusion that turns out to be be wrong. As a Tysabri patient (32 months), I'm impatient to get answers as well. A proper scientific process takes time - first theories and then validation/invalidation of those theories. I'd rather they properly confirm the theories and not run into problems again later.
Chris